Health TrialsbyHealthPanel

Evaluating The Impact of A Mental Health App on Depression and Resilience Among Medical Students

ConditionsDepression - Major Depressive DisorderResilience
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-30
SponsorNational University of Malaysia

About this trial

This randomized controlled trial aims to determine whether access to a mental health app improves resilience and reduces depressive symptoms among medical students over a three-month period.

Compared to the control group, researchers hypothesized that medical students in the intervention group are expected to show:

* Significant reductions in depressive symptoms and greater improvements in resilience after three months of usage. * Significant reduction in thoughts of self-harm and anxiety, and improvement in self-esteem after three months of usage.

Researchers will compare two groups to evaluate the app's impact on wellbeing:

* Intervention group: Receives immediate full access to the mental health app. * Control group: Receives basic, without full access to the mental health app.

Participants will explore and experience the various features offered in the mental health app over a three-month period.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Aged 18 to 30;

Enrolled in medical school (preclinical or clinical years);

Owns a smartphone;

Able to read and understand English.

Disqualifiers

Does not consent to study.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Full digital mental health intervention

    Behavioral

    Name of the mental health app - Intellect: Create A Better You

  • Basic digital mental health intervention

    Behavioral

    Name of mental health app - Intellect: Create a Better You

Treatment groups

220 Participants
are divided into 2 treatment groups
Group A: Intervention GroupExperimental treatment 1 intervention
Group B: Control GroupOther 1 intervention

Trial outcomes

Primary outcomes

1

Depressive symptoms

Depressive symptoms will be assessed using the Patient Health Questionnaire-9, developed by Kroenke et al. (2001). This 9-item instrument assesses the frequency of depressive symptoms over the past two weeks. Each item is rated on a 4-point scale, yielding a total severity score ranging from 0 to 27, with higher scores indicating greater severity of depressive symptoms.

Time frame
Baseline and 3 months
2

Resilience

Resilience will be measured using the Brief Resilience Scale developed by Smith et al. (2008). This 6-item instrument assesses the ability to recover from stress. Each item is rated on a 5-point Likert scale, yielding a total score ranging from 6 to 30, with higher scores indicating greater resilience.

Time frame
Baseline and 3 months

Secondary outcomes

1

Anxiety

Anxiety will be assessed using the Generalized Anxiety Disorder-7 developed by Spitzer et al. (2006). This 7-item instrument assesses generalized anxiety symptoms over the past two weeks. Each item is rated on a 4-point scale, resulting in a total severity score ranging from 0 to 21, with higher total score indicating a greater level of anxiety.

Time frame
Baseline and 3 months
2

Self-esteem

Self-esteem will be measured using the Rosenberg Self-Esteem Scale developed by Rosenberg (1989). This 10-item instrument assesses global self-worth by measuring both positive and negative feelings about the self. Each item is rated on a 4-point Likert scale, yielding a total score ranging from 0 to 30, with higher scores indicating more positive self-esteem.

Time frame
Baseline and 3 months
3

Subjective wellbeing

Subjective wellbeing will be measured using the World Health Organization-Five Well-Being Index. This 5-item instrument assesses the respondent's mental wellbeing over the past two weeks. Each item is rated on a 6-point scale. The raw score is typically multiplied by four to get a percentage score ranging from 0 to 100, with higher scores indicating better mental wellbeing.

Time frame
Baseline and 3 months

Other outcomes

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

Fakulti Perubatan, Universiti Kebangsaan Malaysia Status unavailable Cheras, Kuala LumpurMalaysiaMalaysia

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

National University of Malaysia

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: